Kaleido Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	38.47	46.22	71.24	76.09	28.46
Cash & Short-Term Investments	38.47	46.22	71.24	76.09	28.46
Cash Growth	-16.76%	-35.12%	-6.37%	167.38%	943.11%
Other Receivables	0.93	-	-	-	0.05
Receivables	0.93	-	-	-	0.05
Prepaid Expenses	2.65	2.5	2.04	0.16	0.05
Other Current Assets	0.25	-	-	-	-
Total Current Assets	42.31	48.72	73.28	76.24	28.55
Property, Plant & Equipment	5.67	8.46	6.74	4.69	1.98
Long-Term Deferred Charges	-	-	-	2.21	-
Other Long-Term Assets	2.16	2.16	2.29	2.18	0.22
Total Assets	50.14	59.34	82.31	85.33	30.75
Accounts Payable	5.67	5.39	2.02	3.44	0.86
Accrued Expenses	6.69	7.36	7.09	7.35	2.48
Current Portion of Long-Term Debt	16.14	2.63	-	-	-
Current Portion of Leases	-	-	0.07	0.09	0.1
Current Unearned Revenue	0.83	0.5	-	-	-
Other Current Liabilities	0.35	0.78	1.21	0.42	0.41
Total Current Liabilities	29.68	16.66	10.38	11.3	3.85
Long-Term Debt	5.55	18.38	20.39	14.83	14.81
Other Long-Term Liabilities	4.3	3.81	2.66	2.21	3.27
Total Liabilities	39.53	38.85	33.42	28.34	21.93
Common Stock	0.04	0.04	0.03	0.01	0.01
Additional Paid-In Capital	375.03	294.64	241.41	9.98	0.8
Retained Earnings	-364.47	-274.18	-192.56	-106.23	-44.48
Total Common Equity	10.61	20.5	48.88	-96.24	-43.68
Shareholders' Equity	10.61	20.5	48.88	56.98	8.82
Total Liabilities & Equity	50.14	59.34	82.31	85.33	30.75
Total Debt	21.69	21.01	20.46	14.92	14.91
Net Cash (Debt)	16.78	25.21	50.78	61.16	13.54
Net Cash Growth	-33.45%	-50.35%	-16.97%	351.66%	-
Net Cash Per Share	0.40	0.75	1.98	11.97	3.03
Filing Date Shares Outstanding	42.62	42.47	30.42	5.79	4.71
Total Common Shares Outstanding	42.6	36.02	30.13	5.79	4.71
Working Capital	12.63	32.06	62.9	64.94	24.7
Book Value Per Share	0.25	0.57	1.62	-16.63	-9.27
Tangible Book Value	10.61	20.5	48.88	-96.24	-43.68
Tangible Book Value Per Share	0.25	0.57	1.62	-16.63	-9.27
Machinery	9.02	8.43	5.94	4.56	1.77
Construction In Progress	0.19	1.61	2.65	0.7	-
Leasehold Improvements	1.92	1.91	0.69	0.65	0.64

Updated Apr 1, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.